Nanostring Technologies, Inc. (NSTG)

Trade NSTG now with
3/4/2020 7:27:30 AM NanoString Technologies Reports Proposed Private Offering Of $175 Mln Of Convertible Senior Notes
1/12/2020 7:48:16 PM NanoString Expects Q4 Product And Service Revenue To be $33.6 Mln, Increase Of 42%
11/4/2019 6:05:42 AM NanoString Technologies Announces Availability Of The GeoMx Cancer Transcriptome Atlas
11/4/2019 6:05:20 AM NanoString Technologies Supports Human Cell Atlas To Enable High-plex Spatial Analysis Across Discovery Programs
10/2/2019 6:04:07 AM NanoString Appoints Mark Winham As SVP Of Operations
3/7/2019 4:11:06 PM NanoString Technologies Q4 Loss/share $0.68 Vs. Loss $0.34 Year Ago
1/6/2019 8:05:28 PM NanoString Expects Q4 Product And Service Revenue $23.5 Mln, Exceeding Upper End Of Guidance Of $22 Mln To $23 Mln
11/29/2018 6:05:39 AM NanoString Technologies Highlights Advances In Precision Oncology At The 60th Annual Meeting Of ASH
10/29/2018 6:03:14 AM MacroGenics, NanoString Enter Translational Research Collaboration To Identify And Develop Biomarkers In Immuno-Oncology
9/5/2018 6:04:04 AM NanoString Technologies Launches Priority Site Program For New GeoMx Digital Spatial Profiler
7/23/2018 4:04:50 PM NanoString Technologies Closes Public Offering Of 4 Mln Common Shares
6/4/2018 6:03:31 AM NanoString Technologies Announces Collaboration With CTEP Of The National Cancer Institute
5/31/2018 6:20:24 AM NanoString Highlights Record Number Of Abstracts To Be Presented At ASCO Conference
1/8/2018 5:04:42 AM NanoString Technologies Sees 2017 Product And Service Revenue To Be About $72 Mln
1/4/2018 6:02:11 AM NanoString And RikenGenesis Announce Partnership To Introduce NCounter-Based Diagnostic Assays In Japan
11/4/2014 7:17:48 PM NanoString Technologies, Inc. (NSTG) Has Lowered Its 2014 Revenue Estimate To $46.0 - $48.0 Mln From $45.0 - $50.0 Mln
1/13/2014 8:14:21 AM NanoString Technologies, Inc. (NSTG) Has Raised Its 4Q13 Revenue Estimate To $31.4 Mln From $30.0 Mln - $31.5 Mln